Norbert Garbow

Introduction

Norbert Garbow is an innovative inventor based in Hamburg, Germany. His work focuses on advancing methodologies in the field of cellular technology, particularly concerning the determination of infection sites in cell cultures. With one patent to his name, he represents a significant contribution to research in this specialized area.

Latest Patents

Garbow has developed a notable patent titled "Method for determining the number of sites of infection of a cell culture." This innovative approach involves several steps: infecting a cell culture arranged in a sample carrier with viruses, counting infected areas using transmitted light methods, marking those infected cells with fluorescence markers, and finally conducting fluorescence analysis. The evaluation of the infected areas through both methods demonstrates a thorough and systematic way to quantify infection in cell cultures.

Career Highlights

Currently, Norbert Garbow is associated with PerkinElmer Cellular Technologies Germany GmbH, where he applies his expertise in developing innovative solutions for cellular diagnostics. His role at PerkinElmer has placed him at the forefront of cellular technology advancements, allowing him to engage in research that enhances our understanding of cellular infections and responses.

Collaborations

While specific details about collaborations are not widely publicized, being part of PerkinElmer Cellular Technologies Germany GmbH provides Garbow access to collaborative efforts with top-tier scientists and researchers in the field. This environment contributes to shared knowledge and the potential for future innovations arising from teamwork.

Conclusion

Norbert Garbow's contributions to the field of cellular technology highlight the importance of innovation in research. With his distinctive patent and current role at PerkinElmer, Garbow continues to pave the way for advancements in the understanding and quantification of cellular infections, making a lasting impact on the scientific community.